Fig. 9From: IR792-MCN@ZIF-8-PD-L1 siRNA drug delivery system enhances photothermal immunotherapy for triple-negative breast cancer under near-infrared laser irradiationMechanism graph. AÂ IM@ZP contains two kinds of photothermal molecules (IR792 and MCN), rendering it enhanced photothermal conversion ability. B ZIF-8 releases siRNA into the cytoplasm in the acidic environment of tumor, showing high-efficiency characteristics to downregulate the expression of PD-L1. Under NIR laser irradiation, IM@ZP effectively kills 4T1 tumor cells, induces DC maturation and cytokine secretion to stimulate immune responseBack to article page